Adrenergic signaling promotes angiogenesis through endothelial cell-tumor cell crosstalk

Endocrine-Related Cancer

Volumn 21, Issue 5, 2014, Pages 783-795

  Chen, Hongyu ^a   Liu, Dan ^a   Yang, Zhengyan ^a   Sun, Limin ^a   Deng, Que ^a   Yang, Shuo ^a   Qian, Lu ^a   Guo, Liang ^a   Yu, Ming ^a   Hu, Meiru ^a   Shi, Ming ^a   Guo, Ning ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Angiogenesis; Breast cancer; Catecholamine; Jagged 1; Notch; 2 AR

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CALCIUM BINDING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; MEMBRANE PROTEIN; MESSENGER RNA; NORADRENALIN; NOTCH RECEPTOR; SERRATE PROTEINS; SIGNAL PEPTIDE; TARGET OF RAPAMYCIN KINASE; VASCULOTROPIN A;

ANIMAL; BAGG ALBINO MOUSE; BREAST TUMOR; CELL CULTURE; DRUG EFFECTS; FEMALE; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; TUMOR CELL LINE; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION;

ANIMALS; BREAST NEOPLASMS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; FEMALE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MEMBRANE PROTEINS; MICE, INBRED BALB C; NEOVASCULARIZATION, PATHOLOGIC; NOREPINEPHRINE; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, NOTCH; RNA, MESSENGER; TOR SERINE-THREONINE KINASES; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84907513663     PISSN: 13510088     EISSN: 14796821     Source Type: Journal    
DOI: 10.1530/ERC-14-0236     Document Type: Article

References (54)

1. Barron TI, Connolly RM, Sharp L, Bennett K & Visvanathan K 2011 Beta blockers and breast cancer mortality: a population-based study. Journal of Clinical Oncology 29 2635-2644. (doi:10.1200/JCO.2010.33.5422)
2. Benedito R, Roca C, Sorensen I, Adams S, Gossler A, Fruttiger M & Adams RH 2009 The notch ligands Dll4 and Jagged1 have opposing effects on angiogenesis. Cell 137 1124-1135. (doi:10.1016/j.cell.2009.03.025)
3. Bergers G & Hanahan D 2008 Modes of resistance to anti-angiogenic therapy. Nature Reviews. Cancer 8 592-603. (doi:10.1038/nrc2442)
4. Chakroborty D, Sarkar C, Basu B, Dasgupta PS & Basu S 2009 Catecholamines regulate tumor angiogenesis. Cancer Research 69 3727-3730. (doi:10.1158/0008-5472.CAN-08-4289)
5. Cole SW & Sood AK 2012 Molecular pathways: β-adrenergic signaling in cancer. Clinical Cancer Research 18 1201-1206. (doi:10.1158/1078-0432.CCR-11-0641)
6. Dickson BC, Mulligan AM, Zhang H, Lockwood G, O'Malley FP, Egan SE & Reedijk M 2007 High-level JAG1 mRNA and protein predict poor outcome in breast cancer. Modern Pathology 20 685-693. (doi:10.1038/modpathol.3800785)
7. Dufraine J, Funahashi Y & Kitajewski J 2008 Notch signaling regulates tumor angiogenesis by diverse mechanisms. Oncogene 27 5132-5137.(doi:10.1038/onc.2008.227)
8. Elenkov IJ & Chrousos GP 2002 Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity. Annals of the New York Academy of Sciences 966 290-303. (doi:10.1111/j.1749-6632.2002.tb04229.x)
9. Folkman J 1971 Tumor angiogenesis: therapeutic implications. New England Journal of Medicine 285 1182-1186. (doi:10.1056/NEJM197108122850711)
10. Folkman J 2007 Angiogenesis: an organizing principle for drug discovery? Nature Reviews. Drug Discovery 6 273-286. (doi:10.1038/nrd2115)
11. Funahashi Y, Hernandez SL, Das I, Ahn A, Huang J, Vorontchikhina M, Sharma A, Kanamaru E, Borisenko V, Desilva DM et al. 2008 A Notch 1 ectodomain construct inhibits endothelial notch signaling, tumor growth, and angiogenesis. Cancer Research 68 4727-4735. (doi:10.1158/0008-5472.CAN-07-6499)
12. Hanahan D & Weinberg RA 2000 The hallmarks of cancer. Cell 100 57-70.(doi:10.1016/S0092-8674(00)81683-9)
13. Hanahan D & Weinberg RA 2011 Hallmarks of cancer: the next generation. Cell 144 646-674. (doi:10.1016/j.cell.2011.02.013)
14. Howell D & Olsen K 2011 Distress - the 6th vital sign. Current Oncology 18 208-210.
15. Johnson JD, Campisi J, Sharkey CM, Kennedy SL, Nickerson M, Greenwood BN & Fleshner M 2005 Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 135 1295-1307. (doi:10.1016/j.neuroscience.2005.06.090)
16. Jung YJ, Isaacs JS, Lee S, Trepel J & Neckers L 2003 IL-1β-mediated up-regulation of HIF-1α via an NFκB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis. FASEB Journal 17 2115-2117. (doi:10.1096/fj.03-0329fje)
17. Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I & Karsan A 2007 Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. Journal of Experimental Medicine 204 2935-2948. (doi:10.1084/jem.20071082)
18. Li JL & Harris AL 2005 Notch signaling from tumor cells: a new mechanism of angiogenesis. Cancer Cell 8 1-3. (doi:10.1016/j.ccr.2005.06.013)
19. Li JL, Sainson RC, Shi W, Leek R, Harrington LS, Preusser M, Biswas S, Turley H, Heikamp E, Hainfellner JA et al. 2007 Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo. Cancer Research 67 11244-11253. (doi:10.1158/0008-5472.CAN-07-0969)
20. Loges S, Mazzone M, Hohensinner P & Carmeliet P 2009 Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. Cancer Cell 15 167-170. (doi:10.1016/j.ccr.2009.02.007)
21. Lu J, Ye X, Fan F, Xia L, Bhattacharya R, Bellister S, Tozzi F, Sceusi E, Zhou Y, Tachibana I et al. 2013 Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1. Cancer Cell 23 171-185. (doi:10.1016/j.ccr.2012.12.021)
22. Lutgendorf SK, Lamkin DM, Jennings NB, Arevalo JM, Penedo F, DeGeest K, Langley RR, Lucci JA III, Cole SW, Lubaroff DM et al. 2008 Biobehavioral influences on matrix metalloproteinase expression in ovarian carcinoma. Clinical Cancer Research 14 6839-6846. (doi:10.1158/1078-0432.CCR-08-0230)
23. Lutgendorf SK, Sood AK & Antoni MH 2010 Host factors and cancer progression: biobehavioral signaling pathways and interventions. Journal of Clinical Oncology 28 4094-4099. (doi:10.1200/JCO.2009.26.9357)
24. Ma J, Meng Y, Kwiatkowski DJ, Chen X, Peng H, Sun Q, Zha X, Wang F, Wang Y, Jing Y et al. 2010 Mammalian target of rapamycin regulates murine and human cell differentiation through STAT3/p63/Jagged/Notch cascade. Journal of Clinical Investigation 120 103-114. (doi:10.1172/JCI37964)
25. Madden KS, Szpunar MJ & Brown EB 2011 β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell lines. Breast Cancer Research and Treatment 130 747-758. (doi:10.1007/s10549-011-1348-y)
26. Melhem-Bertrandt A, Chavez-Macgregor M, Lei X, Brown EN, Lee RT, Meric-Bernstam F, Sood AK, Conzen SD, Hortobagyi GN & Gonzalez-Angulo AM 2011 Beta-blocker use is associated with improved relapse-free survival in patients with triple-negative breast cancer. Journal of Clinical Oncology 29 2645-2652. (doi:10.1200/JCO.2010.33.4441)
27. Park SY, Kang JH, Jeong KJ, Lee J, Han JW, Choi WS, Kim YK, Kang J, Park CG & Lee HY 2011 Norepinephrine induces VEGF expression and angiogenesis by a hypoxia-inducible factor-1α protein-dependent mechanism. International Journal of Cancer 128 2306-2316. (doi:10.1002/ijc.25589)
28. Powe DG, Voss MJ, Zanker KS, Habashy HO, Green AR, Ellis IO & Entschladen F 2010 Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget 1 628-638.
29. Powe DG, Voss MJ, Habashy HO, Zanker KS, Green AR, Ellis IO & Entschladen F 2011 Alpha- and beta-adrenergic receptor (AR) protein expression is associated with poor clinical outcome in breast cancer: an immunohistochemical study. Breast Cancer Research and Treatment 130 457-463. (doi:10.1007/s10549-011-1371-z)
30. Rademakers SE, Span PN, Kaanders JH, Sweep FC, van der Kogel AJ & Bussink J 2008 Molecular aspects of tumour hypoxia. Molecular Oncology 2 41-53. (doi:10.1016/j.molonc.2008.03.006)
31. Ranganathan P, Weaver KL & Capobianco AJ 2011 Notch signalling in solid tumours: a little bit of everything but not all the time. Nature Reviews. Cancer 11 338-351. (doi:10.1038/nrc3035)
32. Reedijk M, Odorcic S, Chang L, Zhang H, Miller N, McCready DR, Lockwood G & Egan SE 2005 High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival. Cancer Research 65 8530-8537. (doi:10.1158/0008-5472.CAN-05-1069)
33. Reedijk M, Pinnaduwage D, Dickson BC, Mulligan AM, Zhang H, Bull SB, O'Malley FP, Egan SE & Andrulis IL 2008 JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer. Breast Cancer Research and Treatment 111 439-448. (doi:10.1007/s10549-007-9805-3)
34. Sansone P, Storci G, Tavolari S, Guarnieri T, Giovannini C, Taffurelli M, Ceccarelli C, Santini D, Paterini P, Marcu KB et al. 2007 IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. Journal of Clinical Investigation 117 3988-4002. (doi:10.1172/JCI32533)
35. Semenza GL 2012 Hypoxia-inducible factors in physiology and medicine. Cell 148 399-408. (doi:10.1016/j.cell.2012.01.021)
36. Sennino B & McDonald DM 2012 Controlling escape from angiogenesis inhibitors. Nature Reviews. Cancer 12 699-709. (doi:10.1038/nrc3366)
37. Sethi N, Dai X, Winter CG & Kang Y 2011 Tumor-derived Jagged1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells. Cancer Cell 19 192-205. (doi:10.1016/j.ccr.2010.12.022)
38. Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB, Bottsford-Miller J et al. 2010 Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. Journal of Biological Chemistry 285 35462-35470. (doi:10.1074/jbc.M110.109579)
39. Shawber CJ & Kitajewski J 2004 Notch function in the vasculature: insights from zebrafish, mouse and man. BioEssays 26 225-234. (doi:10.1002/bies.20004)
40. Shi M, Liu D, Duan H, Han C, Wei B, Qian L, Chen C, Guo L, Hu M, Yu M et al. 2010 Catecholamine up-regulates MMP-7 expression by activating AP-1 and STAT3 in gastric cancer. Molecular Cancer 9 269. (doi:10.1186/1476-4598-9-269)
41. Shi M, Liu D, Duan H, Qian L, Wang L, Niu L, Zhang H, Yong Z, Gong Z, Song L et al. 2011 The β2-adrenergic receptor and Her2 comprise a positive feedback loop in human breast cancer cells. Breast Cancer Research and Treatment 125 351-362. (doi:10.1007/s10549-010-0822-2)
42. Shi M, Liu D, Yang Z & Guo N 2013a Central and peripheral nervous systems: master controllers in cancer metastasis. Cancer Metastasis Reviews 32 603-621. (doi:10.1007/s10555-013-9440-x)
43. Shi M, Yang Z, Hu M, Liu D, Hu Y, Qian L, Zhang W, Chen H, Guo L, Yu M et al. 2013b Catecholamine-Induced β2-adrenergic receptor activation mediates desensitization of gastric cancer cells to trastuzumab by upregulating MUC4 expression. Journal of Immunology 190 5600-5608. (doi:10.4049/jimmunol.1202364)
44. Studebaker AW, Storci G, Werbeck JL, Sansone P, Sasser AK, Tavolari S, Huang T, Chan MW, Marini FC, Rosol TJ et al. 2008 Fibroblasts isolated from common sites of breast cancer metastasis enhance cancer cell growth rates and invasiveness in an interleukin-6-dependent manner. Cancer Research 68 9087-9095. (doi:10.1158/0008-5472.CAN-08-0400)
45. Stylianou S, Clarke RB & Brennan K 2006 Aberrant activation of Notch signaling in human breast cancer. Cancer Research 66 1517-1525. (doi:10.1158/0008-5472.CAN-05-3054)
46. Thaker PH, Han LY, Kamat AA, Arevalo JM, Takahashi R, Lu C, Jennings NB, Armaiz-Pena G, Bankson JA, Ravoori M et al. 2006 Chronic stress promotes tumor growth and angiogenesis in a mouse model of ovarian carcinoma. Nature Medicine 12 939-944. (doi:10.1038/nm1447)
47. Thomas JL, Baker K, Han J, Calvo C, Nurmi H, Eichmann AC & Alitalo K 2013 Interactions between VEGFR and Notch signaling pathways in endothelial and neural cells. Cellular and Molecular Life Sciences 70 1779-1792. (doi:10.1007/s00018-013-1312-6)
48. Thurston G & Kitajewski J 2008 VEGF and Delta-Notch: interacting signalling pathways in tumour angiogenesis. British Journal of Cancer 99 1204-1209. (doi:10.1038/sj.bjc.6604484)
49. Villa N, Walker L, Lindsell CE, Gasson J, Iruela-Arispe ML & Weinmaster G 2001 Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels. Mechanisms of Development 108 161-164. (doi:10.1016/S0925-4773(01)00469-5)
50. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y, Dinarello CA & Apte RN 2003 IL-1 is required for tumor invasiveness and angiogenesis. PNAS 100 2645-2650. (doi:10.1073/pnas.0437939100)
51. Xing F, Kobayashi A, Okuda H, Watabe M, Pai SK, Pandey PR, Hirota S, Wilber A, Mo YY, Moore BE et al. 2013 Reactive astrocytes promote the metastatic growth of breast cancer stem-like cells by activating Notch signalling in brain. EMBO Molecular Medicine 5 384-396. (doi:10.1002/emmm.201201623)
52. Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, Barsky SH & Glaser R 2009 Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain, Behavior, and Immunity 23 267-275. (doi:10.1016/j.bbi.2008.10.005)
53. Zender S, Nickeleit I, Wuestefeld T, Sorensen I, Dauch D, Bozko P, El-Khatib M, Geffers R, Bektas H, Manns MP et al. 2013 A critical role for Notch signaling in the formation of cholangiocellular carcinomas. Cancer Cell 23 784-795. (doi:10.1016/j.ccr.2013.04.019)
54. Zeng Q, Li S, Chepeha DB, Giordano TJ, Li J, Zhang H, Polverini PJ, Nor J, Kitajewski J & Wang CY 2005 Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling. Cancer Cell 8 13-23. (doi:10.1016/j.ccr.2005.06.004)